Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-04-29 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于参加厦门辖区上市公司2023年年报业绩说明会暨投资者网上集体接待日活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in a 2023 annual report performance briefing and investor online reception event. It mentions the event date and the topics to be discussed, including 2023 annual performance, governance, strategy, financing plans, and sustainability. The document does not contain the actual annual report or financial data but rather informs about an upcoming investor presentation related to the annual report. The document length is short (595 characters), and it serves as a notice of an event rather than the report itself. Therefore, it fits best under Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position.
2024-04-29 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2024年第一季度报告" which translates to "2024 First Quarter Report". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. There is no indication that this is an announcement or a summary; the full financial data is present. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-29 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2023 Annual General Meeting Resolution Announcement" for the company 大博医疗科技股份有限公司. It details the date and time of the meeting, attendance, voting results on various proposals including the 2023 annual reports, financial statements, profit distribution, and other governance matters. It also includes legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official results and resolutions passed at the Annual General Meeting (AGM), rather than the full annual report or financial statements themselves. The document length is about 6493 characters, which is consistent with a detailed announcement of voting results and resolutions from an AGM. Therefore, this document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-04-29 Chinese
监事会决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2024 first quarter report. It states that the Supervisory Board has reviewed and approved the 2024 Q1 report, confirming its compliance and accuracy. However, the actual quarterly report is not included in this document; instead, it references that the full report is published elsewhere (on the company's designated information disclosure media and a website). The document length is short (656 characters), and it serves as an announcement of the approval and publication of the quarterly report rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself.
2024-04-29 Chinese
关于召开 2023 年年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement about the convening of the 2023 Annual General Meeting (AGM) of 大博医疗科技股份有限公司, including the date, time, venue, voting procedures, agenda items, and related attachments such as proxy forms and voting instructions. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports and proposals will be discussed and voted on. The document length is 6575 characters, which is substantial but the content is clearly an announcement and meeting notice rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2024-04-23 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of temporarily idle raised funds for cash management through low-risk financial products. It details the board and supervisory approvals, investment limits, risk controls, and compliance with regulatory guidelines. The document does not contain financial statements or detailed financial results but is a formal disclosure about the company's financing activities related to the use of raised capital. It is not an annual or interim report, audit report, earnings release, or any other detailed financial report. It fits the category of Capital/Financing Update (CAP) as it updates on the company's use of raised funds and financing activities.
2024-04-18 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.